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    A 52－year－old male was re｛’erred ｛’rom orthopedic surgery in October 1979， who visited with the
chief complaint of right hip pain， Osteolytic change was seen in right iliac， pubic and cranial bones
on X－ray films and were diagnosed a metastatic lesion by iliac bone biopsy． Abdominal aortic angio－
graphy and computed tomography revealed a hypervascular and soft tissue mass in Ieft adrenal gland．
Setum and urine nerepinephrine were 5，01 ng／ml （N＝0．04－O．35 ng／ml） and 1050 ，ugf24h ’iN一一 10．0－
90．0 ptgf24h）． A diagnosis was made as malignant pheochromocytoma with multiple bone metastases．
At the time of admission to our urologic department， serum Ca was 13．3 mg／dl and hypercalcemia
was treated with eel－calcitonin and predonine but serum Ca level was not decreased． Serum pros－
taglandin－Es was as high as 591 pg／rnl （N〈320 pg／ml） and then a potent inhibitor of prostaglandin
synthesis ’indomethacin： 100 mgfday orally） was administrated for 3 days． Prostaglandin－Es and
serum Ca were decreased to 20 pg／lnl and 8．3皿g／ml respectivcly． Serum parathyroid hor皿onc
and nephrogenous cyclic－AMP were within normal range． lt might be throught that the hyper－
calccmia of this patient was caused．．by prostaglandin－Es． The patient hqs been well controlled for
6 months as an out－patient by indomethacin （40 mg／day orally） and phenoxybenzamine （40 mg／day
orally）， the anti－hypercalcemic and anti－hypertensive agents respectively． He developed a mechanical
ileus causcd by obstruction of transverse colon invaded by malignant phcochro皿ocytoma， and then
progressed to septic shock． He died on May 6， 1980． There were no hyperplasia or adenoma in
the parathyroid． The thyroid gland showed no abnormal change． The histological finding of metas－
tatic bone lesion of the right ilium was same as malignant pheochromocytoma of the left adrenal gland
on necropsy．







































尿中17－OHCS 7．7 mg／24 h（N＝3．1～8．7 mg／24 h），
尿中17Ks，3．o mg／24 h（N＝4．2～12．4 mg／24 h），尿
中VMA，186．3mg／24 h（N＝2．0～12．O mg／24 h），尿
Fig． 1． Pelvic bone tomography which shows
   osteolytic change in right pelvic bone．
Fig． 2．Computed tomography which shows low density large mass lesion in upper region of
left kidnev．
内田・ほか＝高PG性高Ca血症・褐色細胞腫
中HvA 6．o mg／24 h（N＝1．0～ILo mg！24 h），血中
adrenaline O・Ol ng／ml（Nく0．12 ng／ml）血中nora－
drenaline 5・olng／ml（N＝＝O．04～o．35 ng／ml），尿中
adrcnaline 1．4 Pt9／24 h（Nく12．0μ9！24 h），尿中no－
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Abdominal aortic angiograpy； Feeding arteries of the tumor were superior， middle and
inferior adrenal arteries．
Fig． 4． Pathological finding in right pelvic bone biopsy． （H－E stain， 100×）
390 泌尿紀要 27巻 4号 1981年
170～152／80～100に調節するようにし，原発巣に対



















恥   ウナギカルシトニン
    12伽
書0凬CンFPtvンン25”t’dey








自9ノ層t   9／29    10／5 10×12 10／30 11115 11122
Fig． 5． Clinical course
内田・ほか＝高PG性高Ca血症・褐色細胞腫
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         高Ca血症の原因
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